The first full trading week of 2026 saw a shift in market leadership. After several weeks of narrow gains driven by mega-cap ...

If you are wondering whether Novo Nordisk shares still offer value or if you might be arriving late, this article focuses ...

The Trump administration will reduce legal immigration, increase deportations and limit the hiring of H-1B visa holders in ...

Travelers on one of Pennsylvania’s busiest highways can expect to pay a bit more starting this weekend. The Pennsylvania ...

An in-depth analysis of PFAS sources, environmental persistence, and health risks, emphasizing the significant role of ...

Enforcement alone is failing. A new governance model—integrating forensic science, community care, and real-time intelligence ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Everyday life is saturated with location-dependent devices. They are multiplying faster than ever and their requirements have ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...

Discover how precedent transaction analysis evaluates company value using past acquisition prices. Understand key factors, data sources, and its advantages and challenges.

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...

Electrum Discovery Corp. is a Canadian based, growth-oriented company, committed to increasing shareholder value through advancement of its two projects: gold-silver Novo Tlamino and copper-gold Timok ...